Asthma
RecruitingA Study of Brenipatide Compared to Placebo for Adults with Uncontrolled Moderate to Severe Asthma
France- Participants:18–64 years
- Substances:LY3537031
- Sponsor:Eli Lilly & Co.
Rare diseases
Investigational molecules
Locations
Back to France18 clinical trials in Montfermeil, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)
France
France
France
France
France
France
France
France
France
France
France
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on acute myocarditis treatment and cardiac arrhythmia management. Research includes evaluation of corticosteroid therapy for improving left ventricular function and investigating preventive measures for premature ventricular complexes.
These trials aim to enhance treatment outcomes for patients with various cardiac conditions.
Advanced research in severe asthma management, exploring new biological therapies and treatment optimization strategies. Studies focus on comparing different therapeutic approaches for patients with eosinophilic phenotypes.
Investigations aim to improve long-term outcomes for patients with severe respiratory conditions.
Comprehensive studies examining treatments for ulcerative colitis, sarcoidosis, and inflammatory eye conditions. Research includes innovative monitoring approaches and medication optimization.
Focus on improving patient outcomes through targeted therapies and personalized treatment approaches.
Investigating innovative treatments for knee osteoarthritis and gout, particularly in patients with complex medical conditions. Studies explore new interventional procedures and medication alternatives.
Research aims to enhance quality of life for patients with chronic joint conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.